Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Cash flows from operating activities:
Net income	$ 221,800	$ 2,218,600
Depreciation and amortization	175,400	153,000
Settlement of contingent consideration (Note 2)	(40,700)	0
Increase in operating capital	(52,400)	(61,400)
Deferred income taxes	35,600	(1,977,600)
Other non-cash items	(41,900)	7,700
Net cash provided by operating activities	297,800	340,300
Cash flows from investing activities:
Purchases of property, plant and equipment	(100,500)	(105,800)
Acquisitions of businesses and assets, net of cash acquired, and other	(1,637,100)	(170,900)
Proceeds from sale of interest in a subsidiary (Note 2)	52,600	0
Net cash used in investing activities	(1,685,000)	(276,700)
Cash flows from financing activities:
Proceeds from long-term debt	1,503,000	486,300
Repayments of long-term debt	(549,000)	(545,600)
Net proceeds from short-term debt	832,300	5,400
Net payments related to share-based compensation awards	(7,500)	(1,300)
Dividends on common stock	(1,500)	(1,500)
Repurchase of common stock	(78,500)	(24,800)
Issuance of common stock for employee stock purchase plan	3,400	2,500
Debt issuance costs	(3,500)	0
Settlement of contingent consideration (Note 2)	(2,200)	0
Net cash provided by (used in) financing activities	1,696,500	(79,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(6,300)	5,000
Net increase in cash, cash equivalents and restricted cash	303,000	(10,400)
Cash, cash equivalents and restricted cash at beginning of period	96,600	116,800
Cash, cash equivalents and restricted cash at end of period	399,600	106,400
Reconciliation of cash flow information:
Cash and cash equivalents	399,200	105,900
Restricted cash included in other current assets	400	500
Total cash, cash equivalents and restricted cash	$ 399,600	$ 106,400